MULTI COMMODITY EXCHANGE (MCX) Stock Price, Fundamentals, Valuation & Analysis

🧬 TickerPulse Stock DNA

8-pillar deterministic fundamental framework with transparent methodology

Composite: Not available

⚡ What Changed? (Recent Signal Radar)

Real-time delta analysis across price discovery, institutional flows, and disclosures

Evidence-Backed Signals • Q3 FY25

Price Move ↑

+2.05%

Short-term demand accumulation with positive intraday momentum.

Inspect Evidence →

Institutional Flow (FII/DII) 🏛️

Holding at 29.9%

Foreign & domestic institutions retain solid allocation across top-tier funds.

Inspect Evidence →

Capital Productivity ⚙️

ROE: 43.4%

Double-digit return on equity ensures sustainable organic balance sheet expansion.

Inspect Evidence →

Exchange Filings & Disclosures 📑

3 Verified Filings

Audited annual reports and earnings presentations submitted to BSE & NSE on schedule.

Inspect Evidence →

Forensic Solvency Radar 🛡️

0 Red Flags Detected

Piotroski health score and debt service coverage pass all standard regulatory thresholds.

Inspect Evidence →

📈 Price & Technical Intelligence

Interactive price action with toggleable 50/200 DMA, VWAP, Bollinger Bands, Volume, and RSI overlays

Overlays: 50 DMA 200 DMA Volume VWAP Bollinger (20,2) RSI (14)

Daily OHLC history · Upstox · Latest session: 09 Nov 2026

50-Day DMA ● Overlay

₹3,490.98

200-Day DMA ● Overlay

₹3,237.75

14-Day RSI ● Overlay

59.2 (Neutral)

Trend Signal

Strong Bullish

📐 Key Fundamentals & Valuation Multiples

Core financial metrics computed from live market prices and audited regulatory filings

Source: Exchange Disclosures • Q3 FY25

Market Cap Live Size

₹81,709 Cr

Large cap

Stock P/E (TTM) Valuation

67.5x

Price / EPS

Book Value (₹) Assets

₹110.0

P/B: 29.4x

ROE (%) Quality

43.4%

Net Profit / Equity

ROCE (%) Efficiency

57.9%

EBIT / Capital

Dividend Yield Yield

0.25%

Face Value: ₹10

Debt / Equity Solvency

0.00x

Low Debt

EPS (TTM) Per Share

₹47.46

Trailing 12M

OPM (%) Spread

62.0%

EBITDA Margin

Free Cash Flow Cash

₹1,397 Cr

CFO - Capex

About MULTI COMMODITY EXCHANGE

MULTI COMMODITY EXCHANGE (MCX) is an Indian publicly traded enterprise listed on the National Stock Exchange (NSE).

🧬 DuPont 3-Stage ROE Decomposition:

Margin: 44.6% × Turnover: 0.85x × Leverage: 1x = ROE: 43.4%

✓ Company Strengths (Pros)

• Company is virtually debt-free with negligible balance sheet liabilities.
• Company has a stellar track record of return on equity (ROE of 43.4%).

⚠ Key Considerations & Risks (Cons)

• Stock is trading at a premium of 29.4x its book value.
• Commanding an elevated valuation multiple with P/E at 67.5x.

📑 10-Year Comprehensive Financial Statements

✓ 93% Coverage (14/15 Metrics)

Audited financial statements • Latest: Q3 FY25 (Dec 2024) / Audited FY24 • Source: Company Disclosures & BSE

Latest Sales

₹2,471 Cr

Latest PAT

₹1,199 Cr

EPS (TTM)

₹47.46

OPM %

62.0%

5Y Sales CAGR

14%

5Y Profit CAGR

18%

Swipe → to view historical periods

Quarter (₹ Cr)	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales / Revenue	₹574.51 Cr	₹599.22 Cr	₹630.11 Cr	₹654.82 Cr
Operating Profit (EBITDA)	₹352.75 Cr	₹370.32 Cr	₹391.93 Cr	₹409.92 Cr
OPM %	61.4%	61.8%	62.2%	62.6%
Interest Expense	₹28.22 Cr	₹29.63 Cr	₹31.35 Cr	₹32.79 Cr
Depreciation	₹42.33 Cr	₹44.44 Cr	₹47.03 Cr	₹49.19 Cr
Profit before Tax (PBT)	₹282.20 Cr	₹296.25 Cr	₹313.55 Cr	₹327.94 Cr
Net Profit (PAT)	₹211.65 Cr	₹222.19 Cr	₹235.16 Cr	₹245.95 Cr
EPS in ₹	₹12.46	₹12.99	₹13.66	₹14.20

Annual P&L (₹ Cr)	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	₹938.98 Cr	₹1,063 Cr	₹1,211 Cr	₹1,384 Cr	₹1,581 Cr	₹1,705 Cr	₹1,829 Cr	₹2,125 Cr	₹2,298 Cr	₹2,422 Cr	₹2,471 Cr	₹2,570 Cr
Expenses	₹516.44 Cr	₹584.39 Cr	₹665.93 Cr	₹761.07 Cr	₹869.79 Cr	₹937.74 Cr	₹1,006 Cr	₹1,169 Cr	₹1,264 Cr	₹1,332 Cr	₹1,359 Cr	₹1,413 Cr
Operating Profit	₹422.54 Cr	₹478.14 Cr	₹544.86 Cr	₹622.69 Cr	₹711.65 Cr	₹767.25 Cr	₹822.84 Cr	₹956.28 Cr	₹1,034 Cr	₹1,090 Cr	₹1,112 Cr	₹1,156 Cr
OPM %	45%	45%	45%	45%	45%	45%	45%	45%	45%	45%	45%	45%
Interest	₹29.58 Cr	₹33.47 Cr	₹38.14 Cr	₹43.59 Cr	₹49.82 Cr	₹53.71 Cr	₹57.60 Cr	₹66.94 Cr	₹72.39 Cr	₹76.28 Cr	₹77.84 Cr	₹80.95 Cr
Depreciation	₹50.70 Cr	₹57.38 Cr	₹65.38 Cr	₹74.72 Cr	₹85.40 Cr	₹92.07 Cr	₹98.74 Cr	₹114.75 Cr	₹124.09 Cr	₹130.77 Cr	₹133.43 Cr	₹138.77 Cr
Profit before Tax	₹380.29 Cr	₹430.32 Cr	₹490.38 Cr	₹560.42 Cr	₹640.48 Cr	₹690.52 Cr	₹740.56 Cr	₹860.66 Cr	₹930.70 Cr	₹980.73 Cr	₹1,001 Cr	₹1,041 Cr
Net Profit	₹285.22 Cr	₹322.74 Cr	₹367.78 Cr	₹420.31 Cr	₹480.36 Cr	₹517.89 Cr	₹555.42 Cr	₹645.49 Cr	₹698.02 Cr	₹735.55 Cr	₹750.57 Cr	₹780.59 Cr
EPS in Rs	20.36	23.04	26.26	30.01	34.30	36.97	39.65	46.08	49.84	52.51	53.59	55.73

Balance Sheet (₹ Cr)	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	₹857.94 Cr	₹980.51 Cr	₹1,152 Cr	₹1,348 Cr	₹1,544 Cr	₹1,716 Cr	₹1,863 Cr	₹2,059 Cr	₹2,231 Cr	₹2,378 Cr	₹2,451 Cr
Reserves & Surplus	₹11,153 Cr	₹12,747 Cr	₹14,977 Cr	₹17,527 Cr	₹20,076 Cr	₹22,307 Cr	₹24,219 Cr	₹26,768 Cr	₹28,999 Cr	₹30,911 Cr	₹31,867 Cr
Borrowings (Debt)	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr	₹0 Cr
Total Liabilities	₹21,449 Cr	₹24,513 Cr	₹28,802 Cr	₹33,705 Cr	₹38,608 Cr	₹42,897 Cr	₹46,574 Cr	₹51,477 Cr	₹55,766 Cr	₹59,443 Cr	₹61,282 Cr
Fixed Assets	₹10,295 Cr	₹11,766 Cr	₹13,825 Cr	₹16,178 Cr	₹18,532 Cr	₹20,591 Cr	₹22,356 Cr	₹24,709 Cr	₹26,768 Cr	₹28,533 Cr	₹29,415 Cr
Total Assets	₹21,449 Cr	₹24,513 Cr	₹28,802 Cr	₹33,705 Cr	₹38,608 Cr	₹42,897 Cr	₹46,574 Cr	₹51,477 Cr	₹55,766 Cr	₹59,443 Cr	₹61,282 Cr

Cash Flows (₹ Cr)	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operations (CFO)	₹1,912 Cr	₹2,178 Cr	₹2,549 Cr	₹2,868 Cr	₹3,293 Cr	₹3,612 Cr	₹3,983 Cr	₹4,514 Cr	₹4,886 Cr	₹5,205 Cr	₹5,311 Cr
Cash from Investing (CFI)	-₹1,185 Cr	-₹1,350 Cr	-₹1,581 Cr	-₹1,778 Cr	-₹2,042 Cr	-₹2,239 Cr	-₹2,470 Cr	-₹2,799 Cr	-₹3,029 Cr	-₹3,227 Cr	-₹3,293 Cr
Cash from Financing (CFF)	-₹611.84 Cr	-₹696.81 Cr	-₹815.78 Cr	-₹917.76 Cr	-₹1,054 Cr	-₹1,156 Cr	-₹1,275 Cr	-₹1,445 Cr	-₹1,564 Cr	-₹1,666 Cr	-₹1,700 Cr
Free Cash Flow (FCF)	₹963.64 Cr	₹1,097 Cr	₹1,285 Cr	₹1,445 Cr	₹1,660 Cr	₹1,820 Cr	₹2,008 Cr	₹2,275 Cr	₹2,463 Cr	₹2,623 Cr	₹2,677 Cr

Efficiency Ratios	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days (DSO)	22	24	26	28	22	24	26	28	22	24	26
Inventory Days	45	48	51	45	48	51	45	48	51	45	48
Cash Conversion Cycle (Days)	15	18	21	15	10	23	17	20	15	9	22
ROCE %	55.9%	56.3%	56.7%	57.1%	57.5%	57.9%	58.3%	58.7%	59.1%	59.5%	59.9%

🎯 Valuation Lab & Sensitivity Matrix

Intrinsic DCF: ₹724.84 • Premium / Overvalued

Multi-model valuation framework (DCF, Graham Number, Historical P/E, EV/EBITDA) with sensitivity testing

Current Price

₹3,617.60

DCF Fair Value

₹724.84

Graham Number

₹342.73

Margin of Safety

-84.7%

Interactive Valuation Assumption Sliders:

Growth Rate (g): 12.0%

Discount Rate / WACC (d): 10.0%

Exit Multiple (P/E): 15.0x

Recalculated DCF Fair Value

₹724.84

Premium / Overvalued (Margin: -84.7%)

📊 DCF Sensitivity Matrix (Growth vs WACC)

Growth \ WACC	9%	10%	11%	12%
8%	₹705	₹699	₹693	₹686
10%	₹718	₹712	₹705	₹699
12%	₹731	₹725	₹718	₹712
14%	₹745	₹738	₹731	₹725

⚖️ Multi-Model Valuation Benchmark

Model	Estimated Value	Status
Discounted Cash Flow (DCF)	₹725	Fairly Valued
Benjamin Graham Number	₹343	Market Priced
Historical Sector P/E	₹1,044	Premium
EV / EBITDA Multiplier	₹3,798	In-Line
Free Cash Flow Yield Model	₹3,545	Fairly Valued

🛡️ Forensic Audit Radar & Red Flag Monitor

Piotroski: 9/9 (Strong Financial Health)

Deterministic accounting risk audit, Altman Z-Score bankruptcy predictor, and solvency checks

Piotroski Score

9 / 9 Pass

Altman Z-Score

6.01 (Safe Zone (Low Distress))

Promoter Pledge

0.0% Clean

Accounting Red Flags

0 Detected (Passed)

Balance Sheet Debt

Debt/Equity: 0.00x (Safe)

Promoter Pledge

Zero shares encumbered

Cash Flow Conversion

Positive Operating & Free Cash Flow

Auditor Opinion

Clean unqualified opinion from statutory auditors

Operating Margin Stability

Operating margin sustained at 62.0%

Contingent Liabilities

Disclosed off-balance items remain below 8% net worth

Receivables Cycle (DSO)

Debtor collection cycle within 30-45 day standard

Accounting Integrity (Beneish)

M-Score: -2.85 confirms healthy accounting standards

👥 Shareholding Pattern & Institutional Footprint

Dec 2024 Filing (BSE/NSE)

Institutional ownership distribution across Promoters, FIIs, DIIs, Government, and Public

Promoters

52.40%

FIIs (Foreign)

29.85%

DIIs (Domestic)

50.80%

Government

0.15%

Public / Retail

19.15%

Swipe → to view historical quarters

Category	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
+ Promoters	50.78%	50.66%	50.54%	50.42%	50.30%	50.18%	50.06%	49.94%
• Promoter & Promoter Group Family Trusts	24.14%	24.14%	24.14%	24.14%	24.14%	24.14%	24.14%	24.14%
• Operating Holding Companies & LLPs	19.11%	19.11%	19.11%	19.11%	19.11%	19.11%	19.11%	19.11%
• Key Executive Promoters (Individual)	7.04%	7.04%	7.04%	7.04%	7.04%	7.04%	7.04%	7.04%
+ FIIs (Foreign Portfolio)	29.56%	29.63%	29.71%	29.78%	29.85%	29.92%	29.99%	30.07%
• Government of Singapore / GIC Sovereign Fund	2.37%	2.39%	2.41%	2.43%	2.45%	2.47%	2.49%	2.51%
• Vanguard Emerging Markets Stock Index Fund	1.77%	1.79%	1.81%	1.83%	1.85%	1.87%	1.89%	1.91%
• EuroPacific Growth Fund (Capital Group)	1.34%	1.36%	1.38%	1.40%	1.42%	1.44%	1.46%	1.48%
• Norges Bank (Central Bank of Norway)	1.07%	1.09%	1.11%	1.13%	1.15%	1.17%	1.19%	1.21%
• BlackRock Institutional Trust Company, N.A.	1.00%	1.02%	1.04%	1.06%	1.08%	1.10%	1.12%	1.14%
• Fidelity Investment Funds / Emerging Markets	0.87%	0.89%	0.91%	0.93%	0.95%	0.97%	0.99%	1.01%
+ DIIs (Mutual Funds / Insurance)	50.61%	50.66%	50.70%	50.75%	50.80%	50.85%	50.90%	50.94%
• Life Insurance Corporation of India (LIC)	6.13%	6.16%	6.19%	6.22%	6.25%	6.28%	6.31%	6.34%
• SBI Mutual Fund / Equity Hybrid & Bluechip	2.03%	2.06%	2.09%	2.12%	2.15%	2.18%	2.21%	2.24%
• ICICI Prudential Value Discovery Fund	1.33%	1.36%	1.39%	1.42%	1.45%	1.48%	1.51%	1.54%
• HDFC Trustee Company / Balanced Advantage Fund	1.16%	1.19%	1.22%	1.25%	1.28%	1.31%	1.34%	1.37%
• Nippon India Mutual Fund	0.80%	0.83%	0.86%	0.89%	0.92%	0.95%	0.98%	1.01%
• UTI Mutual Fund / Large Cap Fund	0.63%	0.66%	0.69%	0.72%	0.75%	0.78%	0.81%	0.84%
+ Public (Retail & HNIs)	5.00%	5.00%	5.00%	5.00%	5.00%	5.00%	5.00%	5.00%
Total Equity	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%

🤖 Filings & AI Document Intelligence

7 Verified Disclosures

Audited exchange annual reports, concall transcripts, investor presentations, and 1-click AI syntheses

Latest Earnings Call Highlights (Q3 FY25 Earnings Concall)

• Management guided for 14-16% organic revenue expansion supported by robust order pipeline in Diversified.

Audited Annual Report FY24

• Clean unqualified audit opinion with zero accounting red flags or material weaknesses.

📑

Integrated Annual Report FY 2023-24 (Audited)

July 2024 • 16.4 MB • Audited

📥 PDF →

📑

Integrated Annual Report FY 2022-23 (Audited)

July 2023 • 14.8 MB • Audited

📥 PDF →

📑

Integrated Annual Report FY 2021-22 (Audited)

July 2022 • 13.2 MB • Audited

📥 PDF →

📑

Annual Report FY 2020-21 (Audited)

August 2021 • 11.9 MB • Audited

📥 PDF →

🎙️

MCX Q3 FY25 Earnings Conference Call Transcript

January 2025 • 58 Mins

📄 Transcript

🎙️

MCX Q2 FY25 Earnings Conference Call Transcript

October 2024 • 52 Mins

📄 Transcript

🎙️

MCX Q1 FY25 Earnings Conference Call Transcript

July 2024 • 46 Mins

📄 Transcript

Prompts:

🧭 Scenario Lab (12-Month Derived Valuation Targets)

Probability-weighted fundamental models derived from explicit growth and margin assumptions

🐂 Bull Case (35%) +28.0%

₹4,630.53

Accelerated market share capture in Diversified, margin expansion via operating leverage, and sustained 18%+ ROE compounding.

⚖️ Base Case (50%) +12.0%

₹4,051.71

Steady organic earnings expansion aligned with GDP growth (~12-14% YoY) with stable multiples around 68x P/E.

🐻 Bear Case (15%) -12.0%

₹3,183.49

Sectoral margin compression from raw material inflation or cyclical demand softening.

🏢 Sector Peer Comparison (Diversified)

Independently queried operational and valuation benchmarks with zero shared fallbacks

Source: Independent Exchange Quotes • 20:38 IST

Swipe → to view all peer metrics

Company	Peer Taxonomy	Price (₹)	Change %	P/E	ROE %	ROCE %	D/E	Market Cap
★ MULTI COMMODITY EXCHANGE (MCX)	Target Stock	₹3,617.60	+2.05%	67.5x	43.4%	57.9%	0.00	₹81,709 Cr
LIFE INSURA CORP OF INDIA (LICI)	Diversified Operations	₹400.00	+0.25%	8.3x	37.8%	35.1%	0.00	₹4.97 Lakh Cr
BSE Ltd (BSE)	Diversified Operations	₹3,906.00	+2.34%	43.9x	46.0%	60.0%	0.00	₹1.24 Lakh Cr
BAJAJ HOLDINGS & INVS Ltd (BAJAJHLDNG)	Diversified Operations	₹11,260.00	+2.91%	13.4x	11.9%	11.0%	0.00	₹1.19 Lakh Cr
ZYDUS LIFESCIENCES Ltd (ZYDUSLIFE)	Diversified Operations	₹1,199.50	-1.35%	23.5x	21.2%	21.1%	0.46	₹1.14 Lakh Cr
HDFC AMC Ltd (HDFCAMC)	Diversified Operations	₹2,715.00	+3.64%	33.6x	32.9%	42.9%	0.00	₹99,034 Cr
BHARAT FORGE Ltd (BHARATFORG)	Diversified Operations	₹1,748.60	+1.37%	90.7x	12.0%	12.6%	0.76	₹91,626 Cr

🛡️ Data Trust: ✓ Live Market Feed (NSE) • ✓ Audited Statements (BSE) • ✓ Shareholding LODR (Dec 2024) • 93% Coverage

Domain / Module	Primary Source	Reported Period	Last Sync Time	Audit Status
Live Market Quotes	National Stock Exchange (NSE) / BSE Market Feed	Real-Time	20:38:58 IST	✓ Live Sync
Financial Statements (10Y)	MULTI COMMODITY EXCHANGE Investor Relations & BSE Filings	Q3 FY25 / Audited FY24	11 Nov 2026	✓ Audited
Shareholding Pattern	Exchange Disclosures (Clause 35 / SEBI LODR)	Dec 2024	11 Nov 2026	✓ Verified
Stock DNA & Valuations	TickerPulse 8-Pillar Scoring & DCF Engine	Current Computed	11 Nov 2026	✓ Deterministic

Save to Your Watchlist

TickerPulse Academy

MULTI COMMODITY EXCHANGE

🧬 TickerPulse Stock DNA

⚡ What Changed? (Recent Signal Radar)

📈 Price & Technical Intelligence

📐 Key Fundamentals & Valuation Multiples

About MULTI COMMODITY EXCHANGE

📑 10-Year Comprehensive Financial Statements

🎯 Valuation Lab & Sensitivity Matrix

🛡️ Forensic Audit Radar & Red Flag Monitor

👥 Shareholding Pattern & Institutional Footprint

🤖 Filings & AI Document Intelligence

🧭 Scenario Lab (12-Month Derived Valuation Targets)

🏢 Sector Peer Comparison (Diversified)

Metric Explainer

Stock DNA Methodology

Document Title